Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing PPCI.
| Registry | NCT04785209 |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 640 (Actual) |
| Sponsor | Assiut University (Other) |
| Conditions | No-Reflow Phenomenon |
| Interventions | Mean platelet volume, lymphocyte number, STEMI clinical risk scores (Other) |
| Dates | start 2020-09-01, primary completion 2021-02-28, completion 2024-05-01, first posted 2021-03-05, last updated 2024-05-31 |
| Locations | 1 site in Egypt |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for No-Reflow Phenomenon All trials of Mean platelet volume, lymphocyte number, STEMI clinical risk scores
Predicting no reflow in ppci of STEMI patients using mean platelet volume together with STEMI clinical risk scores
| Arm | Type | Interventions | Description |
|---|---|---|---|
| No complication | Other: Mean platelet volume, lymphocyte number, STEMI clinical risk scores | Thrombolysis in myocardial infarction flow grade III flow after PPCI, mean platelet volume, lymphocyte ratio, detailed echo within 24 hrs of admission, clinical STEMI risk scores | |
| No reflow | Other: Mean platelet volume, lymphocyte number, STEMI clinical risk scores | No reflow phenomenon after pci on STEMI patients, mean platelet volume, lymphocyte ratio, detailed echo within 24 hrs of admission, clinical STEMI risk scores |
Sex: All, ages: 16 Years to any
Inclusion Criteria: * patients presenting with acute STEMI, within 24 hours of symptoms, fulfilling criteria for PPCI protocol in our facility Exclusion Criteria: * patients presenting more than 24 hours of symptoms onset * patients not eligible for PPCI program in our facility
| Facility | City | Country | Status |
|---|---|---|---|
| Assiut university hospital | Asyut | Egypt |